0001628280-24-023589.txt : 20240515 0001628280-24-023589.hdr.sgml : 20240515 20240515163136 ACCESSION NUMBER: 0001628280-24-023589 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adsett Roger CENTRAL INDEX KEY: 0001685904 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 24951749 MAIL ADDRESS: STREET 1: 10 FINDERNE AVENUE CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 wk-form4_1715805079.xml FORM 4 X0508 4 2024-05-13 0 0001104506 INSMED Inc INSM 0001685904 Adsett Roger 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 0 1 0 0 Chief Operating Officer 0 Common Stock 2024-05-13 4 A 0 14518 A 163077 D Common Stock 2024-05-14 4 S 0 7857 25.50 D 155220 D Stock Option (right to buy) 25.83 2024-05-13 4 A 0 71160 0 A 2034-05-13 Common Stock 71160 71160 D Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. Each RSU was granted on May 13, 2024 for no consideration. Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. This is the weighted average sales price representing 7,857 shares sold at prices ranging from $25.48 to $25.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date. /s/ Roger Adsett, by Michael A. Smith as Attorney-in-fact 2024-05-15